{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:12:12Z","timestamp":1758053532551,"version":"3.44.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,14]]},"DOI":"10.7759\/cureus.92293","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T18:13:51Z","timestamp":1757873631000},"source":"Crossref","is-referenced-by-count":0,"title":["Complete Pathological Response of Human Papillomavirus (HPV)-Related Oropharyngeal Carcinoma After Primary Treatment With Stereotactic Radiotherapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Isaac","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka-Kit David","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin W","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis F","year":"2004","unstructured":"Denis F, Garaud P, Bardet E, et al.. Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004, 22:69-76. 10.1200\/JCO.2004.08.021","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70346-1","article-title":"Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial","volume":"13","author":"Bourhis J","year":"2012","unstructured":"Bourhis J, Sire C, Graff P, et al.. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol. 2012, 13:145-53. 10.1016\/S1470-2045(11)70346-1","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(00)00663-5","article-title":"A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003","volume":"48","author":"Fu KK","year":"2000","unstructured":"Fu KK, Pajak TF, Trotti A, et al.. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000, 48:7-16. 10.1016\/s0360-3016(00)00663-5","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom SS","year":"2021","unstructured":"Yom SS, Torres-Saavedra P, Caudell JJ, et al.. Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002). J Clin Oncol. 2021, 39:956-65. 10.1200\/JCO.20.03128","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group trial (E3311)","volume":"40","author":"Ferris RL","year":"2022","unstructured":"Ferris RL, Flamand Y, Weinstein GS, et al.. Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group trial (E3311). J Clin Oncol. 2022, 40:138-49. 10.1200\/JCO.21.01752","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict SH","year":"2010","unstructured":"Benedict SH, Yenice KM, Followill D, et al.. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010, 37:4078-101. 10.1118\/1.3438081","journal-title":"Med Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.11.013","article-title":"Stereotactic radiation therapy for de novo head and neck cancers: a systematic review and meta-analysis","volume":"6","author":"Malik NH","year":"2021","unstructured":"Malik NH, Kim MS, Chen H, et al.. Stereotactic radiation therapy for de novo head and neck cancers: a systematic review and meta-analysis. Adv Radiat Oncol. 2021, 6:100628. 10.1016\/j.adro.2020.11.013","journal-title":"Adv Radiat Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20200332","article-title":"A systematic review and practical considerations of stereotactic body radiotherapy in the treatment of head and neck cancer","volume":"94","author":"Iqbal MS","year":"2021","unstructured":"Iqbal MS, West N, Richmond N, et al.. A systematic review and practical considerations of stereotactic body radiotherapy in the treatment of head and neck cancer. Br J Radiol. 2021, 94:20200332. 10.1259\/bjr.20200332","journal-title":"Br J Radiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.05.019","article-title":"Stereotactic body radiotherapy: a promising treatment option for the boost of oropharyngeal cancers not suitable for brachytherapy: a single-institutional experience","volume":"82","author":"Al-Mamgani A","year":"2012","unstructured":"Al-Mamgani A, Tans L, Teguh DN, van Rooij P, Zwijnenburg EM, Levendag PC. Stereotactic body radiotherapy: a promising treatment option for the boost of oropharyngeal cancers not suitable for brachytherapy: a single-institutional experience. Int J Radiat Oncol Biol Phys. 2012, 82:1494-500. 10.1016\/j.ijrobp.2011.05.019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2013.07.007","article-title":"Brachytherapy or stereotactic body radiotherapy boost for early-stage oropharyngeal cancer: comparable outcomes of two different approaches","volume":"49","author":"Al-Mamgani A","year":"2013","unstructured":"Al-Mamgani A, Van Rooij P, Sewnaik A, Mehilal R, Tans L, Verduijn GM, Baatenburg de Jong RJ. Brachytherapy or stereotactic body radiotherapy boost for early-stage oropharyngeal cancer: comparable outcomes of two different approaches. Oral Oncol. 2013, 49:1018-24. 10.1016\/j.oraloncology.2013.07.007","journal-title":"Oral Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2022.2159772","article-title":"Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma","volume":"62","author":"Verduijn GM","year":"2023","unstructured":"Verduijn GM, Petit SF, Lauwers I, et al.. Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma. Acta Oncol. 2023, 62:40-7. 10.1080\/0284186X.2022.2159772","journal-title":"Acta Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-01718-w","article-title":"Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer","volume":"15","author":"Vempati P","year":"2020","unstructured":"Vempati P, Halthore AN, Teckie S, et al.. Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer. Radiat Oncol. 2020, 15:278. 10.1186\/s13014-020-01718-w","journal-title":"Radiat Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26384","article-title":"Highly conformal reirradiation in patients with prior oropharyngeal radiation: clinical efficacy and toxicity outcomes","volume":"42","author":"Bagley AF","year":"2020","unstructured":"Bagley AF, Garden AS, Reddy JP, et al.. Highly conformal reirradiation in patients with prior oropharyngeal radiation: clinical efficacy and toxicity outcomes. Head Neck. 2020, 42:3326-35. 10.1002\/hed.26384","journal-title":"Head Neck"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07231-3","article-title":"A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial","volume":"20","author":"Biau J","year":"2020","unstructured":"Biau J, Thivat E, Millardet C, et al.. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial. BMC Cancer. 2020, 20:730. 10.1186\/s12885-020-07231-3","journal-title":"BMC Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2019.1581375","article-title":"Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma","volume":"58","author":"Baker S","year":"2019","unstructured":"Baker S, Verduijn GM, Petit S, et al.. Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma. Acta Oncol. 2019, 58:926-33. 10.1080\/0284186X.2019.1581375","journal-title":"Acta Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25587","article-title":"Locoregional failures and their relation to radiation fields following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma","volume":"41","author":"Baker S","year":"2019","unstructured":"Baker S, Verduijn G, Petit S, Nuyttens JJ, Sewnaik A, van der Lugt A, Heemsbergen WD. Locoregional failures and their relation to radiation fields following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma. Head Neck. 2019, 41:1622-31. 10.1002\/hed.25587","journal-title":"Head Neck"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26342","article-title":"Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer","volume":"42","author":"Gogineni E","year":"2020","unstructured":"Gogineni E, Rana Z, Vempati P, et al.. Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer. Head Neck. 2020, 42:2880-6. 10.1002\/hed.26342","journal-title":"Head Neck"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26138","article-title":"Stereotactic body radiotherapy for medically unfit patients with cancers to the head and neck","volume":"42","author":"Al-Assaf H","year":"2020","unstructured":"Al-Assaf H, Erler D, Karam I, et al.. Stereotactic body radiotherapy for medically unfit patients with cancers to the head and neck. Head Neck. 2020, 42:2050-7. 10.1002\/hed.26138","journal-title":"Head Neck"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00214","article-title":"Stereotactic body radiotherapy as primary treatment for elderly patients with medically inoperable head and neck cancer","volume":"4","author":"Vargo JA","year":"2014","unstructured":"Vargo JA, Ferris RL, Clump DA, Heron DE. Stereotactic body radiotherapy as primary treatment for elderly patients with medically inoperable head and neck cancer. Front Oncol. 2014, 4:214. 10.3389\/fonc.2014.00214","journal-title":"Front Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1269\/jrr.10086","article-title":"Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes","volume":"52","author":"Kodani N","year":"2011","unstructured":"Kodani N, Yamazaki H, Tsubokura T, et al.. Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. J Radiat Res. 2011, 52:24-31. 10.1269\/jrr.10086","journal-title":"J Radiat Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"O'Sullivan B","year":"2013","unstructured":"O'Sullivan B, Huang SH, Siu LL, et al.. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 2013, 31:543-50. 10.1200\/JCO.2012.44.0164","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.1937","article-title":"Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma","volume":"32","author":"Fakhry C","year":"2014","unstructured":"Fakhry C, Zhang Q, Nguyen-Tan PF, et al.. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol. 2014, 32:3365-73. 10.1200\/JCO.2014.55.1937","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30246-2","article-title":"Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study","volume":"18","author":"Chen AM","year":"2017","unstructured":"Chen AM, Felix C, Wang PC, et al.. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study. Lancet Oncol. 2017, 18:803-11. 10.1016\/S1470-2045(17)30246-2","journal-title":"Lancet Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.3300","article-title":"E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx- ECOG-ACRIN cancer research group","volume":"35","author":"Marur S","year":"2017","unstructured":"Marur S, Li S, Cmelak AJ, et al.. E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx- ECOG-ACRIN cancer research group. J Clin Oncol. 2017, 35:490-7. 10.1200\/JCO.2016.68.3300","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II trial of de-intensified chemoradiotherapy for human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"37","author":"Chera BS","year":"2019","unstructured":"Chera BS, Amdur RJ, Green R, et al.. Phase II trial of de-intensified chemoradiotherapy for human papillomavirus-associated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2019, 37:2661-9. 10.1200\/JCO.19.01007","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.06.1888","article-title":"Stereotactic boost and short-course radiotherapy for p16-associated oropharynx cancer (SHORT-OPC): first planned interim safety analysis from a randomized phase II trial","volume":"117","author":"Bahig H","year":"2023","unstructured":"Bahig H, Nguyen-Tan PF, Yuan Y, et al.. Stereotactic boost and short-course radiotherapy for p16-associated oropharynx cancer (SHORT-OPC): first planned interim safety analysis from a randomized phase II trial. Int J Radiat Oncol Biol Phys. 2023, 117:564-5. 10.1016\/j.ijrobp.2023.06.1888","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10807-4","article-title":"A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol","volume":"23","author":"Lee J","year":"2023","unstructured":"Lee J, Nguyen NT, Wright J, et al.. A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol. BMC Cancer. 2023, 23:379. 10.1186\/s12885-023-10807-4","journal-title":"BMC Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS6118","article-title":"A phase III randomized controlled trial comparing palliative stereotactic body radiotherapy vs. palliative standard radiotherapy in patients with advanced head and neck cancer (NCT06641791)","volume":"43","author":"Poon I","year":"2025","unstructured":"Poon I, Karam I, Bahig H, et al.. A phase III randomized controlled trial comparing palliative stereotactic body radiotherapy vs. palliative standard radiotherapy in patients with advanced head and neck cancer (NCT06641791). J Clin Oncol. 2025, 43:TPS6118. 10.1200\/JCO.2025.43.16_suppl.TPS6118","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0403","article-title":"Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers","volume":"13","author":"Karam I","year":"2017","unstructured":"Karam I, Yao M, Heron DE, et al.. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. Future Oncol. 2017, 13:603-13. 10.2217\/fon-2016-0403","journal-title":"Future Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21889","article-title":"Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck","volume":"34","author":"Vargo JA","year":"2012","unstructured":"Vargo JA, Wegner RE, Heron DE, et al.. Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck. Head Neck. 2012, 34:1153-61. 10.1002\/hed.21889","journal-title":"Head Neck"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.3925","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity","volume":"32","author":"Nguyen-Tan PF","year":"2014","unstructured":"Nguyen-Tan PF, Zhang Q, Ang KK, et al.. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. J Clin Oncol. 2014, 32:3858-66. 10.1200\/JCO.2014.55.3925","journal-title":"J Clin Oncol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.05.012","article-title":"Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy","volume":"97","author":"Alfaraj F","year":"2019","unstructured":"Alfaraj F, Craig T, Huang SH, et al.. Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy. Oral Oncol. 2019, 97:124-30. 10.1016\/j.oraloncology.2019.05.012","journal-title":"Oral Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa184","article-title":"Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial","volume":"113","author":"Riaz N","year":"2021","unstructured":"Riaz N, Sherman E, Pei X, et al.. Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial. J Natl Cancer Inst. 2021, 113:742-51. 10.1093\/jnci\/djaa184","journal-title":"J Natl Cancer Inst"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2024-000407","article-title":"Association between rheumatoid arthritis and risk of radiotherapy toxicity: a systematic review","volume":"3","author":"Liebenberg N","year":"2024","unstructured":"Liebenberg N, McWilliam A, Kerns SL, Marshall DC, West CM. Association between rheumatoid arthritis and risk of radiotherapy toxicity: a systematic review. BMJ Oncol. 2024, 3:e000407. 10.1136\/bmjonc-2024-000407","journal-title":"BMJ Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/395180-complete-pathological-response-of-human-papillomavirus-hpv-related-oropharyngeal-carcinoma-after-primary-treatment-with-stereotactic-radiotherapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T18:13:52Z","timestamp":1757873632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/395180-complete-pathological-response-of-human-papillomavirus-hpv-related-oropharyngeal-carcinoma-after-primary-treatment-with-stereotactic-radiotherapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,14]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.92293","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,14]]}}}